Asthma - The Lancet
Asthma-COPD-Medications-Chart-2022_A4_Web.pdf
Use of ICS/LABA Combinations or LAMA Is Associated with a Lower Risk of Acute Exacerbation in Patients with Coexistent COPD and Asthma - ScienceDirect
LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the d | COPD
Asthma & COPD Medications Chart - National Asthma Council Australia
Full article: Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma
Aiming for Clinical Remission in Asthma: The Next Frontier - European Medical Journal
MSC1551 NAC Asthma COPD Medications Chart 2018 HR Internal | PDF | Drugs | Pharmaceutical Sciences
Asthma/COPD - Pulmonary and Sleep Consultants
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
Take a Breath - Asthma COPD Medications and Devices - YouTube
Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization | Journal of Managed Care & Specialty Pharmacy
Evidence Summary - Intermittent Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists for Asthma - NCBI Bookshelf
Optimising treatment for severe asthma - Upham - 2018 - Medical Journal of Australia - Wiley Online Library
Pharmaceuticals | Free Full-Text | Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Comparing LAMA with LABA and LTRA as add-on therapies in primary care asthma management | npj Primary Care Respiratory Medicine
Combination therapy in the treatment of asthma | JAA
Asthma & COPD Medicine Chart (Laminated 5pk) – American Lung Association Health Education Materials
JCM | Free Full-Text | LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Severe Asthma Medications in Paediatrics | Severe Asthma Toolkit
Case report timeline following CARE guidelines. LAMA, long acting... | Download Scientific Diagram
Severe asthma: adding new evidence – Latin American Thoracic Society | European Respiratory Society
Might It Be Appropriate to Anticipate the Use of Long-Acting Muscarinic Antagonists in Asthma? | Drugs
